Gasdermins: Effectors of Pyroptosis

Trends in Cell Biology

Volumn 27, Issue 9, 2017, Pages 673-684

  Kovacs, Stephen B ^a   Miao, Edward A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; gasdermin; inflammasome; programmed cell death; pyroptosis

Indexed keywords

CASPASE 11; GASDERMIN; GASDERMIN A; GASDERMIN B; GASDERMIN C; GASDERMIN D; GASDERMIN E; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MEMBRANE PROTEIN; PROTEIN DFNB59; UNCLASSIFIED DRUG; CASPASE; TUMOR PROTEIN;

CHANNEL GATING; CRYSTAL STRUCTURE; CYTOKINE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PYROPTOSIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; CELL MEMBRANE; METABOLISM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CASPASES; CELL MEMBRANE; HUMANS; INFLAMMASOMES; NEOPLASM PROTEINS; PYROPTOSIS;

EID: 85020444529     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2017.05.005     Document Type: Review

References (77)

1. Jorgensen, I., et al. Programmed cell death as a defence against infection. Nat. Rev. Immunol. 17 (2017), 151–164.
2. Jorgensen, I., et al. Pyroptosis triggers pore-induced intracellular traps (PITs) that capture bacteria and lead to their clearance by efferocytosis. J. Exp. Med. 213 (2016), 2113–2128.
3. Jorgensen, I., et al. IL-1β, IL-18, and eicosanoids promote neutrophil recruitment to pore-induced intracellular traps following pyroptosis. Eur. J. Immunol. 46 (2016), 2761–2766.
4. Moltke Von, J., et al. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490 (2012), 107–111.
5. Sauer, J.-D., et al. Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 12419–12424.
6. Maltez, V.I., et al. Inflammasomes coordinate pyroptosis and natural killer cell cytotoxicity to clear infection by a ubiquitous environmental bacterium. Immunity 43 (2015), 987–997.
7. Aachoui, Y., et al. Canonical inflammasomes drive IFN-γ to prime caspase-11 in defense against a cytosol-invasive bacterium. Cell Host Microbe 18 (2015), 320–332.
8. Maltez, V.I., Miao, E.A., Reassessing the evolutionary importance of inflammasomes. J. Immunol. 196 (2016), 956–962.
9. Saeki, N., Sasaki, H., Gasdermin superfamily: a novel gene family functioning in epithelial cells. Carrasco, J., Mota, M., (eds.) Endothelium and Epithelium, 2012, Nova Science Publishers, 193–211.
10. Shi, J., et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526 (2015), 660–665.
11. Tamura, M., et al. Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner. Genomics 89 (2007), 618–629.
12. Rogers, C., et al. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat. Commun., 8, 2017, 14128.
13. Wang, Y., et al. Chemotherapy drugs induce pyroptosis through caspase -3 cleavage of a Gasdermin. Nature, 2017, 10.1038/nature22393 Published online May 1, 2017.
14. Kayagaki, N., et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526 (2015), 666–671.
15. Ding, J., et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535 (2016), 111–116.
16. He, W.-T., et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 25 (2015), 1285–1298.
17. Saeki, N., et al. Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium. Genes Chromosomes Cancer 48 (2009), 261–271.
18. Liu, X., et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535 (2016), 153–158.
19. Aglietti, R.A., et al. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 7858–7863.
20. Sborgi, L., et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 35 (2016), 1766–1778.
21. Hoffmann, E.K., et al. Physiology of cell volume regulation in vertebrates. Physiol. Rev. 89 (2009), 193–277.
22. McNeil, P.L., Kirchhausen, T., An emergency response team for membrane repair. Nat. Rev. Mol. Cell Biol. 6 (2005), 499–505.
23. Jimenez, A.J., et al. ESCRT machinery is required for plasma membrane repair. Science, 343, 2014 1247136–1247136.
24. Gong, Y.-N., et al. ESCRT-III acts downstream of MLKL to regulate necroptotic cell death and its consequences. Cell, 169, 2017 286–300.e16.
25. Rauch, I., et al. NAIP–NLRC4 inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of caspase-1 and -8. Immunity 46 (2017), 649–659.
26. Martín-Sánchez, F., et al. Inflammasome-dependent IL-1β release depends upon membrane permeabilisation. Cell Death Differ. 23 (2016), 1219–1231.
27. Brough, D., Rothwell, N.J., Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death. J. Cell Sci. 120 (2007), 772–781.
28. Russo, H.M., et al. Active caspase-1 induces plasma membrane pores that precede pyroptotic lysis and are blocked by lanthanides. J. Immunol. 197 (2016), 1353–1367.
29. Chen, K.W., et al. The neutrophil NLRC4 inflammasome selectively promotes IL-1β maturation without pyroptosis during acute Salmonella challenge. Cell Rep. 8 (2014), 570–582.
30. Gaidt, M.M., et al. Human monocytes engage an alternative inflammasome pathway. Immunity 44 (2016), 833–846.
31. Shi, C.-S., et al. Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat. Immunol. 13 (2012), 255–263.
32. Wang, J.-G., et al. Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner. Blood 118 (2011), 2366–2374.
33. MacKenzie, A., et al. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15 (2001), 825–835.
34. Miao, E.A., et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 11 (2010), 1136–1142.
35. Yu, J., et al. Inflammasome activation leads to caspase-1-dependent mitochondrial damage and block of mitophagy. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 15514–15519.
36. Bergsbaken, T., et al. Coordinated host responses during pyroptosis: caspase-1-dependent lysosome exocytosis and inflammatory cytokine maturation. J. Immunol. 187 (2011), 2748–2754.
37. Wu, C., et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol., 10, 2009, R130.
38. Tanaka, S., et al. Functional conservation of Gsdma cluster genes specifically duplicated in the mouse genome. G3 (Bethesda) 3 (2013), 1843–1850.
39. Saeki, N., et al. Gasdermin (Gsdm) localizing to mouse chromosome 11 is predominantly expressed in upper gastrointestinal tract but significantly suppressed in human gastric cancer cells. Mamm. Genome 11 (2000), 718–724.
40. Runkel, F., et al. The dominant alopecia phenotypes Bareskin, Rex-denuded, and Reduced Coat 2 are caused by mutations in gasdermin 3. Genomics 84 (2004), 824–835.
41. Lunny, D.P., et al. Mutations in gasdermin 3 cause aberrant differentiation of the hair follicle and sebaceous gland. J. Invest. Dermatol. 124 (2005), 615–621.
42. Tanaka, S., et al. A new Gsdma3 mutation affecting anagen phase of first hair cycle. Biochem. Biophys. Res. Commun. 359 (2007), 902–907.
43. Li, J., et al. Gsdma3 is required for hair follicle differentiation in mice. Biochem. Biophys. Res. Commun. 403 (2010), 18–23.
44. Zhou, Y., et al. Gsdma3 mutation causes bulge stem cell depletion and alopecia mediated by skin inflammation. Am. J. Pathol. 180 (2012), 763–774.
45. Kumar, S., et al. Gsdma3(I359N) is a novel ENU-induced mutant mouse line for studying the function of Gasdermin A3 in the hair follicle and epidermis. J. Dermatol. Sci. 67 (2012), 190–192.
46. Shi, P., et al. Loss of conserved Gsdma3 self-regulation causes autophagy and cell death. Biochem. J. 468 (2015), 325–336.
47. Guo, H., et al. Gsdma3 is required for mammary gland development in mice. Histochem. Cell Biol. 135 (2017), 2162–2169.
48. Yu, J., et al. Polymorphisms in GSDMA and GSDMB are associated with asthma susceptibility, atopy and BHR. Pediatr. Pulmonol. 46 (2011), 701–708.
49. Hao, K., et al. Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet., 8, 2012, e1003029.
50. Wu, H., et al. Genetic variation in ORM1-like 3 (ORMDL3) and gasdermin-like (GSDML) and childhood asthma. Allergy 64 (2009), 629–635.
51. Moffatt, M.F., et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448 (2007), 470–473.
52. Moffatt, M.F., et al. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 363 (2010), 1211–1221.
53. Das, S., et al. GSDMB induces an asthma phenotype characterized by increased airway responsiveness and remodeling without lung inflammation. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 13132–13137.
54. Chao, K.L., et al. Gene polymorphism linked to increased asthma and IBD risk alters gasdermin-B structure, a sulfatide and phosphoinositide binding protein. Proc. Natl. Acad. Sci. U. S. A. 114 (2017), E1128–E1137.
55. Qiu, R., et al. Genetic variants on 17q21 are associated with ankylosing spondylitis susceptibility and severity in a Chinese Han population. Scand. J. Rheumatol. 42 (2013), 469–472.
56. Chu, A.Y., et al. Multiethnic genome-wide meta-analysis of ectopic fat depots identifies loci associated with adipocyte development and differentiation. Nat. Genet. 49 (2017), 125–130.
57. Kiani, A.K., et al. Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients. Immunogenetics 67 (2015), 277–282.
58. Li, X., et al. Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. J. Allergy Clin. Immunol., 130, 2012 861–8.e7.
59. Hirschfield, G.M., et al. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat. Genet. 42 (2010), 655–657.
60. Kurreeman, F.A.S., et al. Use of a multiethnic approach to identify rheumatoid- arthritis-susceptibility loci, 1p36 and 17q12. Am. J. Hum. Genet. 90 (2012), 524–532.
61. Witsø, E., et al. Genetic determinants of enterovirus infections: polymorphisms in type 1 diabetes and innate immune genes in the MIDIA Study. Viral Immunol. 28 (2015), 556–563.
62. Crosslin, D.R., et al. Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network. Hum. Genet. 131 (2012), 639–652.
63. Watabe, K., et al. Structure, expression and chromosome mapping of MLZE, a novel gene which is preferentially expressed in metastatic melanoma cells. Jpn. J. Cancer Res. 92 (2001), 140–151.
64. Bischoff, A.M.L.C., et al. A novel mutation identified in the DFNA5 gene in a Dutch family: a clinical and genetic evaluation. Audiol. Neurootol. 9 (2004), 34–46.
65. Yu, C., et al. A 3-nucleotide deletion in the polypyrimidine tract of intron 7 of the DFNA5 gene causes nonsyndromic hearing impairment in a Chinese family. Genomics 82 (2003), 575–579.
66. Van Laer, L., et al. Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat. Genet. 20 (1998), 194–197.
67. de Beeck, K.O., et al. DFNA5, a gene involved in hearing loss and cancer: a review. Ann. Otol. Rhinol. Laryngol. 121 (2012), 197–207.
68. Van Laer, L., et al. Mice lacking Dfna5 show a diverging number of cochlear fourth row outer hair cells. Neurobiol. Dis. 19 (2005), 386–399.
69. Delmaghani, S., et al. Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy. Nat. Genet. 38 (2006), 770–778.
70. Schwander, M., et al. A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function. J. Neurosci. 27 (2007), 2163–2175.
71. Delmaghani, S., et al. Hypervulnerability to sound exposure through impaired adaptive proliferation of peroxisomes. Cell 163 (2015), 894–906.
72. Hettema, E.H., et al. Evolving models for peroxisome biogenesis. Curr. Opin. Cell Biol. 29 (2014), 25–30.
73. Harris, S.L., et al. Conditional deletion of pejvakin in adult outer hair cells causes progressive hearing loss in mice. Neuroscience 344 (2017), 380–393.
74. Jorgensen, I., Miao, E.A., Pyroptotic cell death defends against intracellular pathogens. Immunol. Rev. 265 (2015), 130–142.
75. Weinberg, J.M., et al. The role of glycine in regulated cell death. Cell Mol. Life Sci. 73 (2016), 2285–2308.
76. Petrat, F., et al. Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia–reperfusion injury: current knowledge. Br. J. Pharmacol. 165 (2012), 2059–2072.
77. Shaner, N.C., et al. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22 (2004), 1567–1572.